PMGC Holdings Inc. (ELAB)

PMGC Holdings completed the acquisition of SVM Machining, Inc. in February 2026. PMGC Capital acquired a non-controlling equity stake in Nuclea Energy Inc. in November 2025. The company also completed the acquisitions of AGA Precision Systems LLC and Pacific Sun Packaging. Effective January 6, 2026, PMGC Holdings executed a 1-for-4 reverse stock split. NorthStrive Biosciences announced progress updates to the Phase III timeline for its AI-driven drug discovery program with Yuva Biosciences, with results now expected in Q2 2026. The company's stock has experienced significant volatility and a substantial decline.

Demand seasonality varies across PMGC Holdings' business segments. The biopharmaceutical industry can experience seasonal patterns based on medication type. Aesthetic medicine sees peak seasons in spring and summer for treatments like body sculpting and laser hair removal, while fall and winter see increased demand for skin repair treatments. The manufacturing sector encounters seasonal demand fluctuations, requiring manufacturers to adjust operations and inventory.

PMGC Holdings, Inc. operates as a diversified holding company with interests in biopharmaceuticals, physician-dispensed skincare, industrial manufacturing, and investment firms. The company develops and acquires aesthetic medicines and therapeutic products, with a key product being EL-22. It researches, develops, and commercializes topical skincare products featuring Elevai Exosomes. Through subsidiaries, it specializes in CNC machining and precision engineering, serving various markets. The company also engages in medical scientific research and development and operates investment firms.

PMGC Holdings, Inc. has an expansive market presence for its industrial manufacturing sector across North America, Europe, and Asia. Its skincare products have an international reach, including an exclusive distribution deal for Taiwan.

PMGC Holdings Inc. has faced a challenging brand reputation in the past year. Danelfin's AI model assigned ELAB a "Strong Sell" rating with an AI Score of 1/10 as of February 7, 2026, driven by high price volatility, weak fundamental performance, and unfavorable sector and technical patterns. The significant decline in stock price over the past year also reflects negatively on its market perception.

PMGC Holdings Inc. has institutional ownership. Major institutional shareholders include UBS Group AG, Tower Research Capital LLC (TRC), Citigroup Inc, and Bank Of America Corp /DE/. There is conflicting information regarding the percentage of institutional ownership.